THE MCMANUS GROUP for IVX HEALTH
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 14, 2020 | $40,000 | Replaced |
| 2nd Quarter - Termination | Sep 4, 2020 | $40,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Inclusion of COBRA subsidy in coronavirus relief legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Health Issues HCR
Distribution changes in the private market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRYAN CRONAN | — |
| JOHN MCMANUS | — |
| WILLIAM RHYNE | — |
| ALANNA TEMME | LD, Rep. Jon Porter. |
Medicare/Medicaid MMM
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. International Pricing Index model (83 FR 54546). Supervision requirements in CMS-1744-IFC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| WILLIAM RHYNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.